bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.10.30.685644

Multimodal single-cell analysis following SARS-CoV-2 breakthrough infection reveals distinct B cell populations

Abstract

B cells underpin durable immunity by generating long-lived memory B cells and antibody-secreting cells (ASCs) that re-engage upon antigen re-encounter. How human IgG memory B cells are organized to establish, maintain, and reactivate humoral immunity remains incompletely understood. Here, we combine multimodal single-cell profiling with longitudinal characterization of antigen-specific memory B cells following SARS-CoV-2 infection and vaccination to define the developmental relationships and biological functions of human IgG memory B cell subsets. We identify a coordinated activation-memory cycle shared by germinal center- and extrafollicular-derived memory B cells marked by differential CD45RB expression. Within this cycle, activated B cells represent specialized effector cells that acquire inflammatory responsiveness, migratory capacity, and differentiation potential toward ASCs. Activated memory B cells persist as an intermediate that retains migratory capacity while shifting toward homeostatic survival, preserving recall competence and contributing to the regeneration of long-lived resting memory. The resting memory compartment comprises two complementary populations: CD73 resting memory B cells form the principal long-lived recall reservoir, whereas CD24 resting memory B cells adopt a more regulatory resting state and shows limited participation in the SARS-CoV-2 recall response. We further identify a CD24 intermediate population as the earliest transitional state emerging upon memory B cell reactivation, bridging resting memory and the effector recall response. Together, these findings establish the human IgG memory B cell compartment as a dynamic activation-memory cycle rather than a collection of static subsets, providing a framework for understanding humoral immunity and interpreting B cell responses in vaccination, infection, and immune-mediated disease. One sentence summaryOur results provide novel insights on B cell recall responses after SARS-CoV-2 infection or vaccination, formulating distinct classical and non-classical re-activation trajectories from a resting memory state through intermediate phenotypes towards an activated state.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Graus, L. T. M., Guerra, D., Chrysostomou, A., Kerster, G., van der Straten, K., van Rijswijk, J., Tejjani, K., Beaumont, T., Bree, G. J., Sanders, R. W., van Gils, M. J., Claireaux, M.. 2025-10-31. Multimodal single-cell analysis following SARS-CoV-2 breakthrough infection reveals distinct B cell populations. https://doi.org/10.1101/2025.10.30.685644

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗